Nifty
Sensex
:
:
25514.30
83021.75
286.35 (1.14%)
989.94 (1.21%)

Pharmaceuticals & Drugs - API

Rating :
75/99

BSE: 540222 | NSE: LAURUSLABS

2306.00
19-Nov-2026
  • Open
  • High
  • Low
  • Previous Close
  •  2322.5
  •  2328.9
  •  2272.6
  •  2322.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1895387
  •  4355792609.7
  •  2488
  •  917.95

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,24,379.87
  • 92.83
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,26,841.01
  • 0.09%
  • 20.52

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 27.47%
  • 6.80%
  • 20.03%
  • FII
  • DII
  • Others
  • 30.84%
  • 10.61%
  • 4.25%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.59
  • 6.66
  • 10.56

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.87
  • 4.56
  • 17.99

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.60
  • 1.43
  • 74.75

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 37.35
  • 77.27
  • 97.55

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.47
  • 8.48
  • 9.64

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 23.74
  • 28.71
  • 36.48

Earnings Forecasts:

(Updated: 14-11-2026)
Description
2026
2027
2028
2029
Adj EPS
16.47
28.7
35.13
45.49
P/E Ratio
140.01
80.35
65.64
50.69
Revenue
6721.23
8630.42
10163.1
12145.8
EBITDA
1777.71
2726.11
3300.17
4153.07
Net Income
888.79
1548.15
1892.69
2455.65
ROA
8.96
13.54
14.42
15.23
P/B Ratio
23.49
18.31
14.51
11.32
ROE
18.19
25.19
24.42
25.06
FCFF
389.43
-577.57
470.33
1021.4
FCFF Yield
0.29
-0.44
0.36
0.77
Net Debt
2493.12
2955.21
2851.33
2294.52
BVPS
98.18
125.93
158.93
203.67

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 26
Sep 25
Var%
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Net Sales
2,206.37
1,653.47
33.44%
2,026.31
1,569.57
29.10%
1,811.57
1,720.30
5.31%
1,778.29
1,415.05
25.67%
Expenses
1,456.07
1,250.21
16.47%
1,388.04
1,187.44
16.89%
1,299.46
1,299.70
-0.02%
1,298.08
1,129.90
14.88%
EBITDA
750.30
403.26
86.06%
638.27
382.13
67.03%
512.11
420.60
21.76%
480.21
285.15
68.41%
EBIDTM
34.01%
24.39%
31.50%
24.35%
28.27%
24.45%
27.00%
20.15%
Other Income
13.01
26.96
-51.74%
9.18
10.43
-11.98%
11.80
58.57
-79.85%
5.76
9.42
-38.85%
Interest
44.10
40.00
10.25%
42.22
51.50
-18.02%
40.44
56.40
-28.30%
38.79
57.80
-32.89%
Depreciation
127.39
120.49
5.73%
123.87
116.84
6.02%
122.10
110.43
10.57%
120.62
106.09
13.70%
PBT
591.82
269.73
119.41%
481.36
224.22
114.68%
361.37
312.34
15.70%
326.56
130.68
149.89%
Tax
155.08
75.98
104.11%
119.37
63.14
89.06%
79.46
78.47
1.26%
73.45
40.07
83.30%
PAT
436.74
193.75
125.41%
361.99
161.08
124.73%
281.91
233.87
20.54%
253.11
90.61
179.34%
PATM
19.79%
11.72%
17.86%
10.26%
15.56%
13.59%
14.23%
6.40%
EPS
8.17
3.61
126.32%
6.80
3.02
125.17%
5.17
4.33
19.40%
4.66
1.71
172.51%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
7,822.54
6,812.90
5,553.96
5,040.83
6,040.55
4,935.57
4,813.51
2,831.72
2,291.92
2,056.17
1,904.65
Net Sales Growth
23.03%
22.67%
10.18%
-16.55%
22.39%
2.54%
69.99%
23.55%
11.47%
7.96%
 
Cost Of Goods Sold
2,966.77
2,600.52
2,395.08
2,374.35
2,729.67
2,133.89
2,107.62
1,382.88
1,224.80
1,056.02
989.29
Gross Profit
4,855.77
4,212.38
3,158.88
2,666.48
3,310.88
2,801.68
2,705.89
1,448.84
1,067.12
1,000.15
915.36
GP Margin
62.07%
61.83%
56.88%
52.90%
54.81%
56.77%
56.21%
51.16%
46.56%
48.64%
48.06%
Total Expenditure
5,441.65
5,035.19
4,498.68
4,263.33
4,448.36
3,513.14
3,262.83
2,267.17
1,935.93
1,642.85
1,497.01
Power & Fuel Cost
-
371.19
323.40
338.15
324.10
204.47
157.75
136.77
109.37
94.21
66.27
% Of Sales
-
5.45%
5.82%
6.71%
5.37%
4.14%
3.28%
4.83%
4.77%
4.58%
3.48%
Employee Cost
-
815.39
676.44
614.85
557.43
469.55
397.04
320.77
276.33
238.14
204.73
% Of Sales
-
11.97%
12.18%
12.20%
9.23%
9.51%
8.25%
11.33%
12.06%
11.58%
10.75%
Manufacturing Exp.
-
733.32
648.97
611.80
522.90
441.18
364.78
239.50
178.96
150.78
139.47
% Of Sales
-
10.76%
11.68%
12.14%
8.66%
8.94%
7.58%
8.46%
7.81%
7.33%
7.32%
General & Admin Exp.
-
267.73
201.69
157.89
151.15
146.49
133.28
114.23
97.48
73.17
65.42
% Of Sales
-
3.93%
3.63%
3.13%
2.50%
2.97%
2.77%
4.03%
4.25%
3.56%
3.43%
Selling & Distn. Exp.
-
141.32
170.95
134.49
116.14
101.98
91.65
61.53
31.96
24.09
22.65
% Of Sales
-
2.07%
3.08%
2.67%
1.92%
2.07%
1.90%
2.17%
1.39%
1.17%
1.19%
Miscellaneous Exp.
-
105.72
82.15
31.80
46.97
15.58
10.71
11.49
17.03
6.44
22.65
% Of Sales
-
1.55%
1.48%
0.63%
0.78%
0.32%
0.22%
0.41%
0.74%
0.31%
0.48%
EBITDA
2,380.89
1,777.71
1,055.28
777.50
1,592.19
1,422.43
1,550.68
564.55
355.99
413.32
407.64
EBITDA Margin
30.44%
26.09%
19.00%
15.42%
26.36%
28.82%
32.22%
19.94%
15.53%
20.10%
21.40%
Other Income
39.75
54.95
75.10
26.34
6.00
15.30
23.66
5.92
16.15
29.19
33.44
Interest
165.55
170.73
216.00
182.90
165.17
102.39
68.16
89.59
88.19
79.64
99.90
Depreciation
493.98
480.05
430.09
384.58
324.08
251.49
205.07
187.27
164.19
125.45
105.98
PBT
1,761.11
1,181.88
484.29
236.36
1,108.94
1,083.85
1,301.11
293.61
119.75
237.42
235.19
Tax
427.36
292.03
129.88
68.15
312.30
251.42
317.29
38.34
25.99
69.81
43.86
Tax Rate
24.27%
24.71%
26.82%
28.83%
28.16%
23.20%
24.39%
13.06%
21.70%
29.40%
18.65%
PAT
1,333.75
888.50
354.39
166.49
793.37
827.72
983.58
255.27
93.76
167.61
191.33
PAT before Minority Interest
1,341.40
889.85
354.41
168.21
796.64
832.43
983.82
255.27
93.76
167.61
191.33
Minority Interest
7.65
-1.35
-0.02
-1.72
-3.27
-4.71
-0.24
0.00
0.00
0.00
0.00
PAT Margin
17.05%
13.04%
6.38%
3.30%
13.13%
16.77%
20.43%
9.01%
4.09%
8.15%
10.05%
PAT Growth
96.34%
150.71%
112.86%
-79.01%
-4.15%
-15.85%
285.31%
172.26%
-44.06%
-12.40%
 
EPS
24.69
16.44
6.56
3.08
14.68
15.32
18.20
4.72
1.74
3.10
3.54

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
5,300.06
4,472.56
4,110.95
4,037.53
3,351.19
2,597.55
1,769.77
1,558.41
1,482.64
1,330.45
Share Capital
107.97
107.85
107.79
107.73
107.47
107.32
106.91
106.44
106.03
105.76
Total Reserves
5,167.11
4,338.66
3,981.69
3,917.72
3,234.55
2,485.31
1,658.23
1,446.60
1,370.75
1,218.84
Non-Current Liabilities
1,444.40
1,193.33
1,159.18
1,179.48
927.98
692.84
214.24
295.49
174.30
132.34
Secured Loans
611.34
645.58
798.23
761.42
596.34
429.16
165.02
258.71
141.66
124.56
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
132.09
106.09
93.47
81.47
72.67
63.19
45.85
30.05
20.84
14.59
Current Liabilities
3,635.43
3,539.72
3,112.28
2,432.26
2,681.01
2,457.15
1,692.38
1,423.90
1,306.89
1,120.75
Trade Payables
1,252.09
958.49
1,051.24
710.65
876.37
1,178.69
615.63
488.31
312.33
263.10
Other Current Liabilities
798.54
779.68
610.73
640.75
839.73
367.25
261.47
244.50
231.26
199.11
Short Term Borrowings
1,492.64
1,715.01
1,389.29
995.77
910.72
886.12
790.51
684.21
758.52
644.17
Short Term Provisions
92.16
86.54
61.02
85.09
54.19
25.09
24.77
6.89
4.78
14.37
Total Liabilities
10,511.19
9,335.57
8,387.03
7,660.40
6,968.04
5,750.69
3,676.39
3,277.80
2,963.83
2,583.54
Net Block
4,370.64
4,123.22
3,890.01
3,408.62
2,652.47
2,170.62
1,726.34
1,629.07
1,480.80
1,229.93
Gross Block
6,970.29
6,284.33
5,652.20
4,794.82
3,750.20
3,027.97
2,387.71
2,105.42
1,793.75
1,418.58
Accumulated Depreciation
2,599.65
2,161.11
1,762.19
1,386.20
1,097.73
857.35
661.37
476.35
312.95
188.65
Non Current Assets
5,681.98
5,003.25
4,552.06
4,198.72
3,623.43
2,675.83
1,864.33
1,814.84
1,716.23
1,443.71
Capital Work in Progress
773.28
458.36
422.84
550.78
813.22
362.17
67.18
109.63
163.18
143.26
Non Current Investment
309.27
233.26
123.98
49.90
30.81
3.41
3.41
3.40
3.40
3.40
Long Term Loans & Adv.
201.28
163.40
83.50
160.58
84.11
108.52
40.80
25.58
29.36
26.32
Other Non Current Assets
27.51
25.01
31.73
28.84
42.82
31.11
26.60
47.16
39.50
40.80
Current Assets
4,829.21
4,332.32
3,834.97
3,461.68
3,344.61
3,074.86
1,812.06
1,462.96
1,247.59
1,139.82
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
2,342.16
1,936.54
1,845.41
1,684.81
1,760.30
1,575.45
905.22
681.94
584.78
509.05
Sundry Debtors
2,155.04
2,007.16
1,662.92
1,580.44
1,354.18
1,306.06
791.42
709.94
570.59
567.61
Cash & Bank
113.70
144.21
141.65
48.46
75.94
48.46
1.74
3.02
3.06
4.09
Other Current Assets
218.31
37.35
37.83
39.07
154.19
144.89
113.68
68.06
89.16
59.08
Short Term Loans & Adv.
184.14
207.06
147.16
108.90
134.48
88.39
61.91
35.22
58.56
24.91
Net Current Assets
1,193.78
792.60
722.69
1,029.42
663.60
617.71
119.68
39.05
-59.30
19.07
Total Assets
10,511.19
9,335.57
8,387.03
7,660.40
6,968.04
5,750.69
3,676.39
3,277.80
2,963.82
2,583.53

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
1,623.50
601.65
665.69
993.90
911.10
733.00
347.42
297.66
342.49
331.99
PBT
1,181.88
484.29
236.36
1,108.94
1,083.85
1,301.11
293.61
119.75
237.42
235.19
Adjustment
710.40
629.50
562.92
485.71
351.13
254.45
293.21
247.69
216.47
199.38
Changes in Working Capital
25.08
-374.60
-29.02
-315.26
-341.61
-594.06
-199.76
-44.46
-49.48
-52.45
Cash after chg. in Working capital
1,917.36
739.19
770.26
1,279.39
1,093.37
961.50
387.06
322.99
404.41
382.12
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-293.86
-137.54
-104.57
-285.49
-182.27
-228.50
-39.64
-25.32
-61.91
-50.13
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-1,088.66
-681.72
-822.42
-996.06
-914.34
-940.99
-221.13
-252.88
-384.15
-288.67
Net Fixed Assets
-724.73
-360.50
-288.19
-567.41
-1,025.56
-572.84
-236.25
-254.84
-394.43
-354.15
Net Investments
-150.72
-105.35
-250.75
-22.40
-42.83
-260.57
-0.01
-6.57
-1.22
-24.40
Others
-213.21
-215.87
-283.48
-406.25
154.05
-107.58
15.13
8.53
11.50
89.88
Cash from Financing Activity
-524.72
39.28
249.83
-26.64
30.26
254.70
-127.66
-44.77
42.24
-53.61
Net Cash Inflow / Outflow
10.12
-40.79
93.10
-28.80
27.02
46.71
-1.37
0.02
0.59
-10.30
Opening Cash & Equivalents
99.54
138.94
45.67
75.35
48.46
1.69
2.97
3.00
2.42
12.81
Closing Cash & Equivalent
112.66
99.54
138.94
45.67
75.35
48.46
1.69
2.97
3.00
2.42

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
97.71
82.46
75.88
74.73
62.19
48.32
33.02
29.18
27.86
25.05
ROA
8.97%
4.00%
2.10%
10.89%
13.09%
20.87%
7.34%
3.00%
6.04%
8.05%
ROE
18.31%
8.30%
4.15%
21.63%
28.05%
45.15%
15.39%
6.19%
11.97%
18.12%
ROCE
18.20%
10.16%
6.64%
22.97%
25.97%
39.82%
14.14%
8.22%
13.68%
16.52%
Fixed Asset Turnover
1.03
0.93
0.97
1.41
1.46
1.78
1.26
1.18
1.29
1.53
Receivable days
111.49
120.60
117.42
88.66
98.37
79.52
96.76
101.97
100.40
95.66
Inventory Days
114.62
124.27
127.81
104.09
123.34
94.05
102.29
100.87
96.48
94.12
Payable days
155.13
153.14
135.42
106.10
175.76
155.37
145.69
72.80
61.13
59.14
Cash Conversion Cycle
70.98
91.73
109.81
86.64
45.95
18.21
53.36
130.03
135.75
130.64
Total Debt/Equity
0.45
0.61
0.61
0.49
0.52
0.56
0.60
0.67
0.66
0.64
Interest Cover
7.92
3.24
2.29
7.71
11.59
20.09
4.28
2.36
3.98
3.35

News Update:


  • Laurus Labs reports over two-fold jump in Q2 consolidated net profit
    30th Oct 2026, 12:44 PM

    The total consolidated income of the company has increased by 32.07% at Rs 2,219.38 crore for Q2FY27

    Read More
  • Laurus Labs - Quarterly Results
    30th Oct 2026, 00:00 AM

    Read More
  • Laurus Labs invests Rs 107.80 crore in KRKA Pharma
    15th Oct 2026, 12:08 PM

    The percentage of shareholding by the company shall remain same at 49% post this investment

    Read More
  • Laurus Labs invests Rs 12.09 crore in KRPL
    7th Oct 2026, 17:39 PM

    Consequent to this investment, the total holding of the company in KRPL is 2,11,68,000 equity shares of Rs 10 each

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.